Invisalign maker breaks quarterly outlook with bullish action

Invisalign Manufacturer Alignment technology (ALGN) Fourth-quarter results beat expectations Wednesday night, sending ALGN stock back toward its 200-day moving average.


In the fourth quarter of last year, the maker of clear teeth straightening equipment’s sales plunged 6% to $956.7 million, beating estimates of $933.7 million, according to FactSet. Adjusted profit was $2.42 per share, up 13% and above expectations of $2.18.

Align expects total sales to grow by a mid-single-digit percentage in 2024. Analysts who cover ALGN stock estimate sales of $4.02 billion, up 4%.

in after-hours trading Today’s stock marketALGN shares rose more than 10% to 294.40.The stock exceeded 200 day line According to reports, for the first time since December last year

Follow Allison Gatlin on X (formerly Twitter) at @IBD_AGatlin.

You might also like:

Pfizer posts unexpected profit despite continuing sales slump due to coronavirus pandemic

Vertex’s opioid alternative ‘not a game changer’, analysts say

Watch IBD’s investment strategy presentation and learn actionable market insights

Check out the stocks on the Leaders list that are close to buying points

IBD Stock of the Day: Learn how to find, track and buy the best stocks

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button